ATM mutant lymphoid cells are sensitive to olaparib. Effect of increasing doses of olaparib after 7 days exposure on the percentage of surviving cells (logarithmic scale) in ATM null and ATM wild-type LCLs (A), MCL cell lines (B), and proliferating primary CLL cells (C) over a broad range of doses (left) and at lower doses in an expanded cohort (right).